Since tissue based cancer cell PD-L1 expression tends to be associated with tumor infiltrating lymphocytes (TILs) [21, 24], we postulated that cancer cell exposure to lymphocytes in the blood, as is the case for CTCs, may trigger adaptive PD-L1 expression in melanoma CTCs. This evidence concerns the gene CD274 and cancer.